Please login to the form below

Not currently logged in
Email:
Password:

AC Immune

This page shows the latest AC Immune news and features for those working in and with pharma, biotech and healthcare.

Germany’s Vivoryon raises €43m for Alzheimer’s drug trial

Germany’s Vivoryon raises €43m for Alzheimer’s drug trial

The announcement of aducanumab’s demise as well as the failure of AC Immune and Roche’s  crenezumab and other amyloid-targeting agents including Biogen/Eisai’s  elenbecestat and Amgen/Novartis’ 

Latest news

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....